Bio-Techne Corporation Bio-Techne Corporation

Bio-Techne Corporation

TECH

Classifica tra le azioni #1872
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Prezzo delle azioni
$72.55
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$11.38B
Variazione (1 giorno)
0.03%
Variazione (1 anno)
17.27%
Paese
US
Scambia Bio-Techne Corporation (TECH)

Categoria

Healthcare
Numero di azioni in circolazione per Bio-Techne Corporation (TECH)
Numero di azioni in circolazione al June 2026: 155.96M
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Bio-Techne Corporation, il numero attuale di azioni in circolazione è 155.96M. Alla fine del June 2024, la società aveva 157.71M azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Bio-Techne Corporation (TECH) dal 2000 al 2026
Azioni in circolazione alla fine di ogni anno
Anno Azioni in circolazione Cambia
2026 (TTM) 155.96M -0.99%
2025 157.52M -0.12%
2024 157.71M 0.34%
2023 157.18M 0.19%
2022 156.88M 1.22%
2021 154.99M 1.43%
2020 152.80M 1.11%
2019 151.12M 0.81%
2018 149.90M 0.44%
2017 149.25M 0.32%
2016 148.78M 0.26%
2015 148.38M 0.56%
2014 147.56M 0.15%
2013 147.34M -0.28%
2012 147.76M -0.43%
2011 148.39M -0.42%
2010 149.02M -1.45%
2009 151.21M -3.42%
2008 156.56M -0.68%
2007 157.62M 0.91%
2006 156.20M -3.25%
2005 161.44M -1.67%
2004 164.18M -0.78%
2003 165.48M -0.33%
2002 166.03M 0.17%
2001 165.75M 2.00%
2000 162.50M 0.00%
Azioni in circolazione per aziende simili o concorrenti
Azienda Azioni in circolazione Differenza Il paese
253.90M 62.80%
US
396.00M 153.91%
US
478.91M 207.07%
AU
- -
CH
62.19M -60.13%
NL